FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for glipizide, a generic oral therapy for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)